Sourcing N-(4-Oxocyclohexyl)Acetamide: Trace Metals & COA
Pharmaceutical-Grade vs. Standard 99% Purity: Heavy Metal Thresholds for Hydrogenation Catalyst Integrity
When sourcing N-(4-Oxocyclohexyl)acetamide (also known as 4-Acetamidocyclohexanone or N-acetyl-4-aminocyclohexanone) for neurological intermediates, the distinction between pharmaceutical-grade and standard 99% purity is not merely academic—it directly impacts the integrity of downstream hydrogenation steps. In our field experience, residual heavy metals such as palladium, platinum, or nickel from the catalytic hydrogenation of 4-nitroacetophenone can persist at levels that poison sensitive coupling reactions. For a procurement manager, specifying a maximum total heavy metal content of ≤10 ppm is a practical safeguard. Standard 99% material may carry up to 50 ppm of these catalyst residues, which can lead to batch failures in GMP-aligned synthesis. At NINGBO INNO PHARMCHEM, we routinely supply N-(4-Oxocyclohexyl)-acetamide with a palladium content below 2 ppm, verified by ICP-MS on every batch. This is not a marketing claim but a field-verified parameter that prevents costly rework in the production of APIs like donepezil intermediates. For a deeper understanding of how solvent selection and impurity control affect ring-closure reactions, refer to our technical note on optimizing pyrimidine ring closure with N-(4-Oxocyclohexyl)acetamide.
IR Spectral Analysis: Detecting Residual Acetic Acid and Its Impact on Downstream Reductive Amination
A non-standard parameter that often escapes routine QC is the presence of residual acetic acid, a byproduct of the acetylation step in the manufacturing process. In our production, we have observed that even 0.1% w/w acetic acid can shift the pH of a reductive amination mixture, leading to incomplete conversion and the formation of dimeric impurities. IR spectroscopy is our frontline tool: the carbonyl stretch of acetic acid at 1710 cm⁻¹ is distinct from the ketone band of the chemical building block at 1715 cm⁻¹, but in practice, a shoulder on the main peak is often the only clue. We recommend that procurement managers request an IR spectrum with each COA and look for a flat baseline between 1680 and 1730 cm⁻¹. This edge-case behavior is particularly pronounced when the material has been stored in non-vented containers, where acetic acid can accumulate. Our bulk transit protocols for winter moisture control also address how packaging choices mitigate this risk during shipment.
Critical COA Data Points: Trace Metal Limits, Impurity Profiles, and Batch-Specific Verification Protocols
A robust COA for N-(4-Oxocyclohexyl)acetamide must go beyond assay and melting point. Based on our experience supplying this organic synthesis intermediate to pharmaceutical clients, the following table outlines the parameters we consider non-negotiable for neurological intermediate applications:
| Parameter | Typical Specification (Pharma Grade) | Standard Grade | Analytical Method |
|---|---|---|---|
| Assay (GC) | ≥99.5% | ≥99.0% | GC-FID |
| Total Heavy Metals | ≤10 ppm | ≤50 ppm | ICP-MS |
| Palladium (Pd) | ≤2 ppm | Not specified | ICP-MS |
| Residual Acetic Acid | ≤0.05% | ≤0.2% | IR or HPLC |
| Water (Karl Fischer) | ≤0.5% | ≤1.0% | KF titration |
| Single Largest Impurity | ≤0.1% | ≤0.5% | GC/HPLC |
Batch-to-batch consistency is maintained through rigorous in-process controls. For instance, we monitor the crystallization endpoint by tracking the solution's turbidity at 600 nm; a deviation of more than 0.02 AU from the standard curve indicates a polymorphic shift that can alter the material's reactivity. Procurement managers should verify that the global manufacturer provides a detailed impurity profile, not just a total impurity count. The presence of 4-aminocyclohexanone (the deacetylated form) at levels above 0.1% is a red flag, as it can act as a competing nucleophile in subsequent steps. Please refer to the batch-specific COA for exact numerical specifications.
Bulk Packaging and Logistics: IBC and 210L Drum Specifications for Industrial-Scale Sourcing
For industrial-scale procurement, packaging is a critical factor in maintaining quality assurance. N-(4-Oxocyclohexyl)acetamide is a crystalline solid with a melting point around 102–104°C, but it can sinter in warm climates. We supply this industrial purity intermediate in 210L steel drums with a polyethylene liner, net weight 25 kg, or in 500 kg IBCs for bulk orders. A field-tested precaution: during winter transit, static discharge can cause clumping of the fine powder. Our drums are equipped with anti-static liners and we recommend grounding during dispensing. The bulk price is significantly influenced by the packaging choice; IBCs reduce handling costs but require dedicated unloading equipment. For a seamless drop-in replacement for your current source, our material matches the physical and chemical specifications of major suppliers, ensuring no reformulation is needed. We do not claim EU REACH compliance, but our packaging meets international transport standards for chemical solids.
Frequently Asked Questions
What are the acceptable batch-to-batch consistency metrics for N-(4-Oxocyclohexyl)acetamide in neurological intermediate synthesis?
Consistency is measured by the relative standard deviation (RSD) of the assay, impurity profile, and physical properties across at least three consecutive batches. For pharmaceutical applications, an RSD of less than 0.5% for assay and less than 10% for individual impurities is expected. We also track the particle size distribution (D50) as a proxy for dissolution rate; a shift of more than 15% can indicate a process drift.
What is the acceptable loss on drying (LOD) variation, and how does it affect downstream reactions?
LOD is typically specified as ≤0.5% by Karl Fischer titration. A variation of ±0.2% is acceptable, but higher moisture can hydrolyze the acetamide group over time, generating acetic acid. In our experience, LOD above 0.8% correlates with a 2–3% decrease in yield in moisture-sensitive reactions like Grignard additions.
What documentation is required for GMP-aligned supply chains?
At a minimum, you should receive a certificate of analysis (COA) with trace metal data, a certificate of origin, and a material safety data sheet (SDS). For GMP production, a statement of GMP compliance, residual solvent analysis, and a supply chain audit trail are often requested. We provide a comprehensive technical dossier with each shipment.
What is the common name for N 4 hydroxyphenyl acetamide?
The common name for N-(4-hydroxyphenyl)acetamide is paracetamol or acetaminophen. This is a different compound from N-(4-Oxocyclohexyl)acetamide, which is a ketone derivative used as a synthetic intermediate.
Sourcing and Technical Support
As a global manufacturer of N-(4-Oxocyclohexyl)acetamide, NINGBO INNO PHARMCHEM provides a reliable drop-in replacement for your current source, with identical technical parameters and competitive bulk price. Our technical support team can assist with method transfer and impurity identification. For more details on our product, visit our N-(4-Oxocyclohexyl)acetamide product page. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.